Skip to content

Retinopathy Of Prematurity Stage 5a C4703696

Published: July 22, 2026Updated: August 20, 2026

The most severe form of ROP, where complete retinal detachment causes near-total vision loss. It affects premature infants born very early or with low birth weight. Treatment aims to preserve any remaining vision through surgery, but blindness is common.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
H53.9
ICD-11
9A00.0
Body system
ophthalmologic
Severity
critical
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Generalized symptoms

Symptoms may be severe and require urgent medical attention.

Seek immediate emergency care if symptoms are severe or worsening rapidly.

!

Partial retinal detachment

!

Visual acuity limited to light perception

Photophobia

(ophthalmologic)

Esotropia

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lens-Sparing Vitrectomy

Vitreous surgery technique that preserves the natural lens while removing tractional membranes and achieving retinal reattachment.

surgical
2

Outpatient procedure with monitoring

Requires immediate emergency medical intervention. Do not delay treatment.

procedure
3

Combined Vitrectomy with Perfluorocarbon Liquid

Use of heavy liquids during surgery to flatten subretinal membranes and facilitate retinal reattachment in complex Stage 5a presentations.

procedure

Additional treatment options

Postoperative Corticosteroid Therapy

Topical or systemic anti-inflammatory medication to control postoperative inflammation and prevent synechiae formation.

medication

Electroretinogram and Imaging Studies

Objective assessment of retinal function and structure using ERG, OCT, and B-scan ultrasonography to guide treatment decisions.

monitoring

Visual Development Stimulation Program

Structured early intervention program combining残余 vision stimulation with sensory integration activities to support cortical visual development.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Call emergency services (911) immediately

!

Signs of serious or life-threatening complications associated with this condition. Immediate medical evaluation is required.

Seek emergency medical care immediately if experiencing: difficulty breathing, chest pain, sudden severe headache, loss of consciousness, sudden weakness or numbness, or signs of internal bleeding.

Frequently asked questions

Common questions about this topic.

Q

What is Retinopathy Of Prematurity Stage 5a C4703696?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Fierson WM, American Academy of Pediatrics Section on Ophthalmology. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018.

guideline2018
2

Hartnett ME, McColm JR. Long-term structural and functional outcomes after targeting vascular endothelial growth factor for retinopathy of prematurity treatment. Invest Ophthalmol Vis Sci. 2020.

clinical_trial2020
3

Quinn GE, Ying GS. Progress in understanding and managing retinopathy of prematurity. JAMA Ophthalmol. 2021.

review2021
4

Sankar MJ, Chandra P. Anti-vascular endothelial growth factor agents for type 1 ROP: a systematic review and meta-analysis. Lancet Child Adolesc Health. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Retinopathy Of Prematurity Stage 5a C4703696. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy